Literature DB >> 20599926

Involvement of tryptophan W276 and of two surrounding amino acid residues in the high constitutive activity of the ghrelin receptor GHS-R1a.

Catherine Gozé1, Gilbert Bergé, Céline M'Kadmi, Nicolas Floquet, Didier Gagne, Jean-Claude Galleyrand, Jean-Alain Fehrentz, Jean Martinez.   

Abstract

The human ghrelin receptor (GHS-R1a) is known to display a high level of signaling in the absence of ligand. The Trp276, located in the fully conserved CWXP motif of G protein-coupled receptors, is believed to function as a rotameric switch in these receptors. A comparative modelling of GHS-R1a with the motilin receptor, the most related G protein-coupled receptor to GHS-R1a known to date, but characterized by a very low ligand-independent signaling level, revealed that only two surrounding residues of Trp276, that are Val131 and Ile134, were different from these receptors. We mutated them at once in GHS-R1a to create a "motilin receptor-like" environment of Trp276 in order to study the consequences on GHS-R1a activation. We studied the pharmacological properties of the W276A, V131L-I134M GHS-R1a mutants. Basal as well as maximal ghrelin-induced signaling was assessed both by inositol-phosphate accumulation and SRE pathways. As compared to the wild type receptor, the SRE-luciferase assay displayed a markedly impaired basal activity for W276A whereas that of V131L-I134M was, strikingly, two fold increased. Nevertheless, the efficacy of ghrelin to bind or to stimulate mutant receptors remained unchanged. It is concluded that Trp276, Val131 and Ile134 have a significant impact on constitutive signaling of GHS-R1a, V131L-I134M being the first example of a GHS-R1a mutant with a higher basal activity than the wild type receptor. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20599926     DOI: 10.1016/j.ejphar.2010.06.018

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  Structural Model of Ghrelin Bound to its G Protein-Coupled Receptor.

Authors:  Brian Joseph Bender; Gerrit Vortmeier; Stefan Ernicke; Mathias Bosse; Anette Kaiser; Sylvia Els-Heindl; Ulrike Krug; Annette Beck-Sickinger; Jens Meiler; Daniel Huster
Journal:  Structure       Date:  2019-01-24       Impact factor: 5.006

Review 2.  Functionally biased signalling properties of 7TM receptors - opportunities for drug development for the ghrelin receptor.

Authors:  B Sivertsen; N Holliday; A N Madsen; B Holst
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

3.  Normosmic congenital hypogonadotropic hypogonadism due to TAC3/TACR3 mutations: characterization of neuroendocrine phenotypes and novel mutations.

Authors:  Bruno Francou; Jérôme Bouligand; Adela Voican; Larbi Amazit; Séverine Trabado; Jérôme Fagart; Geri Meduri; Sylvie Brailly-Tabard; Philippe Chanson; Pierre Lecomte; Anne Guiochon-Mantel; Jacques Young
Journal:  PLoS One       Date:  2011-10-21       Impact factor: 3.240

4.  Buzhongyiqi Decoction Protects Against Loperamide-Induced Constipation by Regulating the Arachidonic Acid Pathway in Rats.

Authors:  Wan-Jun Ju; Ze-Kuo Zhao; Shao-Li Chen; Dan-Dan Zhou; Wen-Ning Yang; Xiao-Ping Wen; Guang-Li Du
Journal:  Front Pharmacol       Date:  2020-04-03       Impact factor: 5.810

5.  Side Chain Orientation of Tryptophan Analogues Determines Agonism and Inverse Agonism in Short Ghrelin Peptides.

Authors:  Lennart Nicke; Ronny Müller; Armin Geyer; Sylvia Els-Heindl
Journal:  ChemMedChem       Date:  2019-09-16       Impact factor: 3.466

6.  Two families with normosmic congenital hypogonadotropic hypogonadism and biallelic mutations in KISS1R (KISS1 receptor): clinical evaluation and molecular characterization of a novel mutation.

Authors:  Frédéric Brioude; Jérôme Bouligand; Bruno Francou; Jérôme Fagart; Ronan Roussel; Say Viengchareun; Laurent Combettes; Sylvie Brailly-Tabard; Marc Lombès; Jacques Young; Anne Guiochon-Mantel
Journal:  PLoS One       Date:  2013-01-18       Impact factor: 3.240

7.  GHS-R1a constitutive activity and its physiological relevance.

Authors:  Yves Mear; Alain Enjalbert; Sylvie Thirion
Journal:  Front Neurosci       Date:  2013-05-29       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.